Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Contenu indisponible. Consultez la source originale.
Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths